American Cannabis News

Cresco Labs Reports 11% Q2 Revenue Decline – New Cannabis Ventures

Published

7 months ago

August 17, 2025

admin

Cresco Labs Reports 11% Q2 Revenue Decline – New Cannabis Ventures

CRESCO LABS SOLID Q2 PAINTING AND DEPARTMENT Refinancing The basis for the creation of long-term value

Chicago- (Business Wire) – CRESCO LABS INC. (CL) (OTCQX: CRLBF) (FSE: USD, unless otherwise stated and available on the company’s investors’ website, here.

The second quarter 2025 important events

The income of the second quarter of $ 164 million. The second quarter, which operates cash flow, $ 9 million.
Gross profit: $ 83 million. Adjusted gross profit – $ 83 million; and adjusted gross margin in the amount of 50.6% of income.
SG & A $ 51 million or 31.4% of income.
The net loss of $ 14 million includes an unresolved charging of $ 9 million in California’s assets.
The second quarter adjusted Ebitda¹ to $ 41 million and adjusted Ebitda margin, 25.0%.
Maintained the position of shares # 1 in many billion dollars markets.

Management Comment:

In Q2, we showed strongly in accordance with the guidance, preserved the share of our market in a high competitive environment and continued to make cash with our balance and maintains our balance sheet. Near time priorities and long-term growth opportunities. “

“The hemp industry enters a new phase, which is defined by consolidation and intelligence. choice partner as a consolidation of industry. “

Balance, liquidity and other financial information

As of June 30, 2025, current assets amounted to $ 315 million, including cash and cash equivalents, $ 147 million. The company had a senior secured credit loan debt, discount and release costs, $ 354 million and mortgage loans, discount net and release costs.
The shares of voting on a fully converted basis were 483.444.948, as of June 30, 2025.

_{“Non-GAAP FINANCIAL” “NON GAAP FINANCIAL”, the company’s non-GAP financial measures for the use of financial events.}

_{²Achding to Hoodie Analytics.}

Conference call and web wash

The company will host a conference call and web web, on Thursday, August 7, 2025, Eastern time. 30 o’clock at 8 o’clock. On 30. The conference call can access WEBCAST or 1-433-470-1428 or 1-404-975-4839 (Local) provides 158138 access code.

CRESCO LABS INC.

CRESCO LABS mission is to normalize the cannabis industry and professionalize the construction of national brands and the construction of a customer-based retail experience, while a business economy for existing legislative and regulatory initiatives. As a leader of cultivation, production and brand distribution, the company uses its scale and agility to grow its brands portfolio, which includes CRESCO, High Supply, Floracal, Good news, Mindy’s and Remedi, Mindy’s and Remedi. The company also operates very effective dispenses, which are located under the Sunnyside brand, which focus on the construction of the patient’s and consumer confidence during continuous education and convenience. Efforts to the Community Area and Seed Initiative throughout the Policy, CRESCO Labs presents the responsibility of supporting communities through valid involvement, economic opportunities, investments, labor, and legislative initiatives, which have been developed as possible. Learn more about Cresco Labs travel by visiting www.crescolabs.com or Following the company on Facebook, X or LinkedIn.

Original press release

Published by NCV NewsWire

NCV NewsWire aims to treat high-quality content and information about cannabis companies by New Cannabis Ventures to help our readers make noise and remain the most important cannabical business news. NCV Newswire is hand treated by hand and is not automated. Have secret news tip. Contact:A number

Related Topics:Cannabis Cresco Decline Labs Reports Revenue Ventures

Up Next

The 3 Big MSOs Report Q2 – New Cannabis Ventures

Don't Miss

Verano Q2 Revenue Falls 9% – New Cannabis Ventures

American Cannabis News

Trulieve Q4 Revenue Falls 3% – New Cannabis Ventures

Published

2 days ago

March 1, 2026

admin

On February 26, 2026 at 6:29 am

Published by NCV Newswire

Trulieve reports 2025 Q4 and full-year results with 60% gross margin and record cash flow generation

Full year revenue of $1.2 billion with a gross margin of 60%
2025 record cash flow from operations of $273 million and free cash flow of $229 million*
A record 50.1 million branded products sold in 2025, up 5% from last year

TALLAHASSEE, Fla., Feb. 26, 2026 /PRNewswire/ — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “The Company”), the leading and top performing cannabis company in the United States, today announced its results for the fourth quarter and full year ended December 31, 2025. Numbers may not add up perfectly due to rounding.

2025 Full Year Financial and Operating Highlights*

Revenue is $1.2 billion with 94% of revenue coming from retail.
Achieved 60% gross margin, with GAAP gross profit of $711 million.
A net loss attributable to common stockholders of $116 million was reported. Adjusted net loss of $27 million excludes non-recurring charges, asset impairments, disposals and discontinued operations.
Achieved record adjusted EBITDA of $427 million*, or 36% of revenue, up $7 million, or 2%, from 2024.
Generated record cash flow from operations of $273 million and free cash flow of $229 million*.
The cash amount at the end of the year was 256 million dollars.
Repaid $368 million of senior secured notes and repaid $15.8 million of mortgages in 2026.
Private placement of $140 million of senior secured notes due 2030.
Conditional approval granted for a Distributorship license under the Texas Compassionate Use Program.
Grown the rewards program to 915,000 members as of December 31, 2025.
11 dispensaries were added in 2025, with 233 retail locations nationwide at the end of the year.

_{*See “Non-GAAP Financial Measures” below for additional information and reconciliations to GAAP for all non-GAAP measures.}

Q4 2025 Financial and Operating Highlights*

Revenue was $293 million, with 93% of revenue coming from retail.
Achieved 60% gross margin, with GAAP gross profit of $175 million.
A net loss attributable to common stockholders of $43 million was reported. Adjusted net loss of $3 million excludes non-recurring charges, asset impairments, disposals and discontinued operations.
Achieved adjusted EBITDA of $105 million* or 36% of revenue.
Cash flow from operations of $59 million and free cash flow of $56 million*.
A new mobile app serving Florida customers has been released, enabling patients to browse and reserve products, view promotions and check reward status in a seamless digital experience.
Opened one dispensary in Findlay, Ohio.

_{*See “Non-GAAP Financial Measures” below for additional information and reconciliations to GAAP for all non-GAAP measures.}

Recent developments

Opened one dispensary in Fort Myers, Florida.
Closed second tranche of $60 million private placement of senior secured notes due 2030.
There are currently 234 retail dispensaries and more than four million square feet of processing and processing capacity in the United States.

Management Commentary

“We finished the year strong, winning a conditional license in Texas and repositioning our debt,” said Trulieve CEO Kim Rivers. “With a re-planning on the horizon, Trulieve is driving its momentum through 2026, prioritizing expanded reach, loyal customers, branded products and growth initiatives.”

Original press release

Published by NCV Newswire

New Cannabis Ventures’ NCV Newswire aims to gather high-quality content and information about leading cannabis companies to help our readers filter through the noise and stay on top of the most important cannabis business news. The NCV Newswire is edited by an editor and, however, is not automated. Got a secret news tip? Get in touch.

aawh

Share Repurchases Are Not Always a Good Idea for Cannabis Companies – New Cannabis Ventures

Published

3 days ago

February 28, 2026

admin

You are reading this week’s edition of New Cannabis Ventures, a weekly magazine we have published since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve, as well as links to the most important news of the week. We no longer email them like we used to, but post this and all newsletters on our website here.

friends,

Earnings season kicked off this week, and so far it’s been a mixed bag. Green Thumb Industries beat expectations, while Trulieve missed. Cronos Group also missed adjusted EBITDA despite falling revenue.

What’s most interesting to me about these quarterly reports are the updates we get in documents or press releases. A large category is share buybacks that are done.

GTI, which has a strong balance sheet, especially compared to other MSOs, has bought back more inventory. Cronos Group, which is cash- and debt-free, also bought some shares in November and December. These shares were acquired at close to tangible book value.

Trulieve did not report the share buyback, but the 10-K disclosed a 2025 bonus announced on 2/24 for CEO Rivers. The company has net cash, but its tangible book value is very negative and has deteriorated. The company does not buy back shares.

Ascend is set to report Q4 financials on 3/12 and it will be interesting to see if this very cheap stock company continues to buy back shares. The company has negative tangible book value, and the GTI 10-K disclosed that Ascend paid a $17 million penalty to GTI on 2/12, so I don’t expect it to be as aggressive with buybacks.

Stock buybacks seem like a good thing, especially when valuations are so low. However, investors should be wary of hemp companies buying back shares when they have balance sheet challenges.

Sincerely,

Alan:

New Cannabis Ventures publishes curated articles as well as exclusive news. Here is what we have published in the last 2 weeks.

Exclusives

Canadian cannabis sales hit a new record high in December

Michigan hemp sales began in 2026

Financial statements

Green Thumb Industries’ revenue is rising as profitability improves

Trulieve Q4 revenue down 3%

Capital increase

Curaleaf took out $500M over 3 years at 11.5%

GTI increases borrowings by $50 million

Follow Alan for real-time updates X.com:. Share and discover industry news with like-minded people on the largest group of cannabis investors and entrepreneurs LinkedIn:.

View: Public Hemp Company Revenue and Earnings Trackingwhich ranks the highest-earning hemp stocks.

Stay on top of the most important communications from public companies by watching what’s coming cannabis investor calendar.

Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El

AKAN

Cannabis Stocks Held Steady – New Cannabis Ventures

Published

4 days ago

February 27, 2026

admin

Hemp stocks, as measured by the Global Hemp Stock Index, were quite volatile in 2024 and then again in 2025 as well. Although the index rose in December, it fell on the year. In January, the indicator decreased by 10.6%, reaching 5.89. February saw a drop in prices, but the market recovered with the index ending the month at 5.86, down 0.5%.

After collapsing 21.8% in late 2024 to 6.88 in Q4, the index fell heavily in Q1 and then marginally in Q2. The global hemp stock index, which now has 27 members, gained 53.0% in the third quarter but fell 14.2% in the fourth quarter, down 4.2% for the full year. In 2026, it decreased by 11.1%.

Since its peak in February 2021, the global hemp stock index is down 93.7% from a closing high of 92.48.

The 3 strongest names in February, each an MSO, were all up more than 13%;

Jazz Pharma rallied in 2026, but the other two declined.

February’s 3 weakest names are all down more than 13%;

All three have fallen significantly in 2026 so far.

We will summarize the performance of the index again in a month. In April, we historically combined the two articles, and we update here the other indexes that New Cannabis Ventures continues to maintain: the American Cannabis Operator Index, the Ancillary Cannabis Index, and the Canadian Cannabis LP Index.

American Hemp Operator Index

The ACOI sank in January, falling 12.5% to 11.53, and fell further in February, falling 5.8% to 10.87. In 2025, it increased by 57.7% to 13.18 and decreased by 17.5% in 2026. The large AdvisorShares Pure US Cannabis ETF ( MSOS ) fell 3.7% in February.

The strongest performing stock in February was TerrAscend (OTC: TSNDF ), up 7.7%. The weakest, Vireo Growth (OTC: VREOF ), fell 17.9%.

In March, the index will have seven members with the removals of Jushi Holdings (OTC: JUSHF ) and Vireo Growth.

Auxiliary cannabis index

Ancillary commodities lost 5.7% in February as the index fell to 9.84. The index decreased by 19.5% in 2025, reaching 11.09, and this year it decreased by 11.3%.

The strongest stock in February was Turning Point Brands (NASDAQ: TPB ), which rose 13.1%. The weakest iPower fell by 55.8%.

In March, the index will have seven members after the removal of GrowGeneration (NASDAQ: GRWG ), iPower (NASDAQ: IPW ) and Chicago Atlantic BDC (NASDAQ: LIEN ) during February’s low trading volume.

Canadian Hemp LP Index

Canadian LPs fell 0.9% in February as the index fell to 55.65. In 2025, the index increased by 17.8%, reaching 59.01, and in 2026, it decreased by 5.7%.

The strongest Canadian LP in February was Rubicon Organics (TSXV: ROMJ ), which rose 8.9%. Simply Insoluble Concentrates (TSXV: HASH ) was the weakest, down 27.8%.

In March, the index will have the same thirteen members.